Comparison of Conservative Methods for the Treatment of Lateral Epicondylitis: A Randomized, Prospective Study
1 other identifier
interventional
200
1 country
1
Brief Summary
This is a prospective study where patients with lateral epicondylitis (tennis elbow) will be randomized into one of 4 possible treatments. The purpose is to individually examine the efficacy of each treatment, and determine if one treatment method is more effective than another. The four treatments are: corticosteriod injections, prolotherapy, NSAIDs (non-steroidal anti-inflammatory drugs) combined with physical therapy, and a placebo.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_2
Started Mar 2012
Longer than P75 for phase_2
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2012
CompletedFirst Submitted
Initial submission to the registry
June 11, 2012
CompletedFirst Posted
Study publicly available on registry
July 11, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2019
CompletedJanuary 25, 2018
January 1, 2018
7.3 years
June 11, 2012
January 23, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Symptom Severity in pre intervention assessments
12 months
Symptom severity in post-intervention assessments
12 months
Secondary Outcomes (2)
Functional status score pre-intervention
12 months
Functional status score severity- post intervention
12 months
Study Arms (4)
Corticosteroid Injections
ACTIVE COMPARATORPatients will receive 1 cc Kenalong 10 mg injection to the site every 6 weeks until clinical symptoms have resolved. They will also receive an anesthetic of 1cc 1% lidocaine in conjunction with the corticosteroid injection.
Prolotherapy
ACTIVE COMPARATORParticipants receive 1cc 50% Dextrose and 1 cc Sodium Morrhuate to the site every 6 weeks until symptoms resolve. These participants will also receive an anesthetic of 1cc 1% lidocaine.
Placebo
PLACEBO COMPARATORParticipants will recieve placebo injections (1cc 1% lidocaine and 1cc normal saline).
Physical Therapy
ACTIVE COMPARATORParticipants will be prescribed NSAIDS (Diclofenac 75 mg BID) for 2 weeks. Participants will attend therapy for muscle stretches, soft tissue mobilization, and gradual strengthening.
Interventions
Participants in the placebo group will recieve placebo injections (1cc 1% lidocaine and 1cc normal saline).
Subjects participating in the physical therapy group will attend physical therapy and be prescribed to NSAIDS. No prolotherapy or corticosteroid injections.
Participants in the corticosteroid group will recieve corticosteroid injections (1 cc Kenalog 10 mg). They will also recieve anesthetic of 1 ml 1% lidocaine.
Subjects participating in the prolotherapy group will recieve 1 cc 50% Dextrose and Sodium Morrhuate 1 cc injections.
Eligibility Criteria
You may qualify if:
- pain over the lateral epicondyle (via palpation over the lateral epicondyle, resisted wrist extension, resisted finger extension of the middle finger) for less than six-months duration prior to enrollment
- conservative treatment of tennis elbow is recommended as standard of care treatment
- over the age of 18 and under the age of 65
- ability to give informed consent
You may not qualify if:
- treatment by a health care profession (MD, physicians assistnat, therapist, or nurse practitioner) within the previous 6 months for tennis elbow
- congenital deformities, tendon ruptures, or fractures of the elbow within the previous 12 months
- immobility casts or splints within the last 6 months for tennis elbow
- co-existing elbow diagnosis (i.e. osteoarthritis or instability)
- pregnant women, women trying to get pregnant, or breastfeeding women
- under the age of 18 or over the age of 65
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Christine M. Kleinert Institute of Hand and Microsurgery
Louisville, Kentucky, 40202, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Tuna Ozyurekoglu, MD
Christine M. Kleinert Institute for Hand and Microsurgery
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 11, 2012
First Posted
July 11, 2013
Study Start
March 1, 2012
Primary Completion
June 1, 2019
Study Completion
June 1, 2019
Last Updated
January 25, 2018
Record last verified: 2018-01